Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) reported Total revenues for the quarter ended March 31, 2016 were approximately $6.8 million, compared with $1.2 million during the same period in 2015. Total revenues for the quarter consisted of Auryxia net U.S. product sales of $5.6 million, and license revenue of $1.2 million associated with royalties received on ferric citrate net sales from Keryx’s Japanese partner.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) belongs to Healthcare sector. Its weekly performance is 0.38%. On last trading day company shares ended up at $5.26. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) distance from 50-day simple moving average (SMA50) is 14.03%.
Gannett Co., Inc. (NYSE:GCI) reported Operating revenues for the quarter were $659.4 million compared to $717.4 million in the prior year, a decrease of $58.0 million or 8.1%. This decline is partially due to approximately $14.6 million related to the reporting of sales of certain third party (principally Cars.com and CareerBuilder) digital advertising products on a net basis (as described above), $5.4 million of unfavorable foreign currency exchange rate changes and $5.4 million of selected exited operations and other items.
Gannett Co., Inc. (NYSE:GCI) shares decreased -4.27% in last trading session and ended the day at $16.81. GCI Gross Margin is 35.30% and its return on assets is 6.20%. Gannett Co., Inc. (NYSE:GCI) quarterly performance is 16.90%.
Limelight Networks, Inc. (NASDAQ:LLNW) reported revenue of $41.4 million for the first quarter which ended March 31, 2016, down 2 percent, compared to $42.3 million in the first quarter of 2015, and down 1 percent when adjusting for the impact of foreign currency fluctuations. GAAP gross margin was 40.2% in the first quarter of 2016, an increase of 120 basis points from 39.0% in the first quarter of 2015.
On 28 April, Limelight Networks, Inc. (NASDAQ:LLNW) shares decreased -4.62% and was closed at $1.75. LLNW EPS growth in last 5 year was -0.30%. Limelight Networks, Inc. (NASDAQ:LLNW) year to date (YTD) performance is 20.21%.
Transcat Inc. (NASDAQ:TRNS) has purchased Excalibur Engineering Inc., a California-based provider of calibration services, test equipment and product rentals. The all-cash deal was announced earlier this month for $7.35 million and marks at least the fourth acquisition in roughly three years for the Ogden-based calibration services provider and test equipment distributor
Transcat Inc. (NASDAQ:TRNS) ended the last trading day at $10.69. Company weekly volatility is calculated as 2.82% and price to cash ratio as 369.87. Transcat Inc. (NASDAQ:TRNS) showed a weekly performance of 4.60%.
Prosperity Bancshares, Inc.® (NYSE:PB), the parent company of Prosperity Bank® (collectively, “Prosperity”), reported net income for the quarter ended March 31, 2016 of $68.951 million or $0.98 per diluted common share. Additionally, nonperforming assets remain low at 0.29% of first quarter average earning assets.
Prosperity Bancshares Inc. (NYSE:PB) shares decreased -0.29% in last trading session and ended the day at $52.11. PB return on assets is 1.30%. Prosperity Bancshares Inc. (NYSE:PB) quarterly performance is 27.81%.